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Abstract
Background and Objectives:
Endobronchial ultrasoundguided transbronchial needle aspiration (EBUSTBNA) is a relatively new
procedure initially used for lung cancer diagnosis, staging and restaging and extended to benign diseases
such as sarcoidosis and other mediastinal lesions. Previously, multiple studies evaluated the use of needle
biopsy with no aspiration that did not change the diagnostic accuracy compared with needle biopsy
aspiration.
Materials and Methods:
All adult subjects who were scheduled to undergo EBUSTBNA to sample mediastinal lesions were
eligible. We evaluated two methods of sampling mediastinal lesions. The first method was the application
of negative pressure syringe for needle suction aspiration. The second was with no suction. For every
patient and every biopsy site in the same patient, we had two samples using each method.
Results:
Among the 26 participants, 24 patients had adequate tissue using both methods (92.3%, P = 1.00). Among
the 24 patients with adequate tissue using both methods, 14 patients (58.3%) had benign pathology using
both methods, whereas ten patients (41.7%) had malignant pathology using both methods (P = 1.00).
Among the 32 sites that were sampled, 30 sites had adequate tissue using both methods (93.8%, P = 1.00).
Among the thirty sites with adequate tissue using both methods, 17 (56.7%) had benign pathology using
both methods; 12 (40.0%) had malignant pathology using both methods; and one site (3.3%) had
malignant pathology using suction, but benign pathology using no suction (P = 1.00).
Conclusion:

https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4445168/?report=printable

1/10

3/7/2018

Comparison of cytologic accuracy of endobronchial ultrasound transbronchial needle aspiration using needle suction versus no suction

In patients undergoing EBUSTBNA to sample mediastinal lesions, the diagnostic yield with the
application of suction to needle biopsy was not statistically significant compared to no suction.
Keywords: Endobronchial ultrasound, mediastinal, suction, transbronchial needle aspiration

INTRODUCTION
Endobronchial ultrasoundguided transbronchial needle aspiration (EBUSTBNA) is a relatively novel,
rapidly growing diagnostic modality that allows accurate sampling of mediastinal lymph nodes (LNs) and
other peribronchial lesions. EBUSTBNA is a minimally invasive, safe and cost effective technique, with
high yield cytologic diagnosis.[1] Although it is mainly used for lymphnode staging and diagnosis of lung
cancer, EBUSTBNA might also be used for the diagnosis of unexplained mediastinal and hilar
lymphadenopathy, as well as other mediastinal lesions.[2,3,4] Since its introduction in 2004,[3] EBUS
TBNA use is becoming widely variable and includes restaging lung tumors, diagnosing sarcoidosis and
evaluation of patients with extrathoracic malignancies. EBUSTBNA has a high yield for diagnosing and
staging lung cancer that ranges from 89% to 98%,[2,3,5,6] and better when compared to computed
tomography (CT) and positive emission tomography (PET) scan.[5] It also reduces the need for surgical
mediastinal staging. EBUSTBNA was diagnostic in 8893% of patients with sarcoidosis and mediastinal
lymphadenopathy,[1] and provided superior diagnostic yield compared to conventional TBNA.[7]
Cytologic studies that included data on patients who underwent EBUSTBNA revealed adequate samples
rate ranging from 60% to 95%. Although it is the gold standard, and relatively safe procedure,
mediastinoscopy is more invasive and compared to EBUSTBNA, it carries higher complication and
mortality rates.[8] Additionally, few studies revealed higher diagnostic yield for EBUSTBNA compared
to cervical mediastinoscopy.[9,10]
Endobronchial ultrasoundguided transbronchial needle aspiration is performed under realtime US
guidance, which leads to significant diagnostic improvement compared to conventional TBNA.[7,11] The
EBUS bronchoscope is equipped with a conventional bronchoscopic fiberoptic component to identify
airway anatomy, a linear US scanning probe for realtime imaging and a biopsy channel for a 22 or 21
gauge aspiration needle. The integrated color Doppler allows easy identification of vascular structures.
Technically, once the LN or mass has been clearly identified with EBUS, the needle is inserted through the
working channel under realtime US guidance. The stylet of the needle is left in place on the first puncture;
once the needle tip is inside the lesion, the stylet is used to clean the tip of the needle from any bronchial
contamination. After removing the stylet, the standard of care is to apply suction using a negative pressure
syringe (20 mL) and the needle is stabbed multiple times. The needle is removed, and the specimen is
expelled onto glass slides using a 10 or 20 mL airfilled syringe or by reinserting the stylet. The slides are
then airdried, or alcohol fixed or sent as cellblock specimen.
In general, bronchoscopists apply negative pressure to needle sampling except when rapidonsite
evaluation is requested, and the first sample returned bloody materials. In this case subsequent samples are
taken without suction to minimize the risk of inadequately bloody specimen. Since its first introduction in
1930,[12] aspiration biopsy was latter described by many authors as modified fineneedle aspiration
(FNA) without aspiration in diagnosing breast, thyroid and lung lesions.[13,14] Currently, there are no data
showing that applying negative pressure to FNA needle biopsy leads to higher diagnostic accuracy.
However, several studies showed that FNA without suction resulted in better specimen adequacy.
[13,14,15,16] This was explained by decreased tissue trauma and blood cell return into the needle when no
suction was applied. The objective of our study is to compare cytologic diagnostic accuracy between
EBUSTBNA samples using suction versus no suction.

MATERIALS AND METHODS
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This is a noninferiority study between EBUSTBNA suction and no suction techniques. We prospectively
enrolled consecutive patients presenting to our endoscopy suite for EBUSTBNA between February and
November 2011. All procedures were performed by K.H. and (M.C.) and only patients to be performed by
these 2 doctors were enrolled in the study. All patients were adults and have an outpatient chest CT scans
that were reviewed prior to the procedure, and some of the patients had PET scan as well. All lesions to be
biopsied were measured in their short axis. Only LNs that were above 1 cm in size were included in the
study.
Our institutional review board approved the study, and written consent was obtained for all patients
undergoing the bronchoscopic procedure. The study did not carry any additional risk compared to routine
EBUSTBNA procedure. Patients were medicated with midazolam and meperidine for the procedure. In
all patients, local anesthesia was performed with 4% lidocaine; 2 cc were injected in each nostril and 4 cc
were used for gargling then swallowed. All patients were given 2 L/min of oxygen via nasal cannula and
increased as needed during the procedure. The procedure was performed using the US bronchoscope
Olympus BFUC160FOL8 connected to US processor EUC60; Olympus. Transbronchial aspiration was
performed using a 22gaugeneedle (Olympus NA201SX4022) in all patients. Realtime US was used in
all EBUSTBNA, and when indicated, colored Doppler was used to prevent accidental vascular punctures.
The LNs to be biopsied localized methodically based on their stations. Each site was punctured using 2
methods. The first method is when we apply negative pressure using 20 mL syringe for needle suction and
we called it EBUSTBNA and suction (EBUSTBNAS), and the second is when no needle suction is
applied after needle site puncture and we called it EBUSTBNA and no suction (EBUSTBNANS).
Needle punctures were performed using the jabbing method followed by the stylet withdrawal then “to and
fro” movement inside the lesion for 10 times. The stylet was removed in both methods. The aspirates were
expelled onto slide glass using a 20 mL airfilled syringe then fixed with alcohol (95% ethanol). Every site
was punctured four times, twice for each technique. In the EBUSTBNAS group, the second puncture was
performed with a suction even if the first one yielded bloody specimen. The EBUSTBNANS was
performed first to prevent needle contamination with cancerous cells and thus prevented false results. In
addition, two or more punctures using 20 cc syringe suction were performed and sent as cellblock
specimen. The additional punctures were not included in the analysis and were used for clinical purposes
only. The collected samples were sent for the cytopathological evaluation, and all pathologists were
blinded to sampling methods by using labeling the specimen with alphabetic letters. Rapid onsite
evaluation was not performed in all cases. We collected our pathology data using our institutional
electronic system. The biopsy was considered adequate if there were lymphocytes or specific diagnosis
such as malignancy reported by the Cytopathologist. The biopsies were considered inadequate if there
were no lymphocytes or specific diagnosis seen on any slides. The primary outcomes are the diagnostic
yield and specimen adequacy of EBUSTBNA with and without suction for mediastinal lymphadenopathy.
We excluded patients who were not able to complete the EBUS procedure for any reason.

STATISTICA ANALYSIS
Patient and LN characteristics [Table 1] were reported by mean and range for continuous variables, and the
frequency and relative frequency for categorical variables. Sensitivity and specificity are estimated with
Wilson 95% confidence intervals. McNemar test was used to check the equality of sensitivities between
the two diagnostic techniques at a significance level of 0.05.

RESULTS
Among the 26 participants, one of the patients (3.8%) had no adequate tissue using both methods; one
patient (3.8%) had adequate tissue using suction, but no adequate tissue using no suction; and 24 patients
had adequate tissue using both methods (92.3%, P = 1.00). Among the twentyfour patients with adequate
tissue using both methods, 14 patients (58.3%) had benign pathology using both methods, while ten
https://www-ncbi-nlm-nih-gov.medproxy.hofstra.edu/pmc/articles/PMC4445168/?report=printable
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patients (41.7%) had malignant pathology using both methods (P = 1.00). Considering suction to be the
golden method, the sensitivity and specificity of no suction were 100% [Figure 1]. The 95% CI for
sensitivity and specificity, are 0.721.00 and 0.781.00 respectively.
Among the 32 sites, which were sampled, one site (3.1%) had no adequate tissue using both methods; one
site (3.1%) had adequate tissue using suction but no adequate tissue using no suction; and 30 sites had
adequate tissue using both methods (93.8%, P = 1.00). Among the thirty sites with adequate tissue using
both methods, 17 (56.7%) had benign pathology using both methods; 12 (40.0%) had malignant pathology
using both methods; and one site (3.3%) had malignant pathology using suction, but benign pathology
using no suction (P = 1.00). Considering suction to be the golden method, the no suction had a sensitivity
= 92.3% (95% CI: 0.670.99) and specificity = 100% (95% CI: 0.771.00) [Figure 2]. For the site that had
no adequate tissue with no suction, but adequate tissue with suction, the no suction specimen was totally
dry, and we were unable to obtain any specimen.
Of the 32 sites punctured, 16 were at the station 7 (50%), 12 were at station 4R (37.5%), 2 were 10R
(6.2%), 1 was at station 4L (3.1%), and one was lung mass (3.1%) [Table 1]. Of the 26 patients enrolled in
the study, 10 patients (38.4%) had a diagnosis of malignancy, of which 4 (40%) were small cell lung
cancer and 6 (60%) were nonsmall lung cancer. Only one of the 10 patients with malignancy had a
positive result with EBUSTBNAS and negative with EBUSTBNANS. This was at the subcarinal
(station 7) LN site and therefore did not affect the adenocarcinoma lung staging in this patient as the
patient had EBUSTBNAS and EBUSTBNANS both positive for malignant cells at another N2 LN
stage (4R). 21 of 26 patients had underlying lung lesions in association with the mediastinal LNs. All 10
patients diagnosed with malignancy had lung lesions mainly in the upper lobes (5/10). Of the other 14
patients with adequate tissue using both methods, 5 patients did not have underlying lung lesions, of which
one was diagnosed with sarcoidosis with EBUSTBNA, 2 had some nonspecific peripheral lung opacities
and ended up having usual interstitial pneumonia as final diagnosis and two patients were considered non
malignant after decreasing size with subsequent chest CT followups. Only 1 of the 14 patients with
benign biopsies using both methods yielded to a specific diagnosis (7.1%), which was sarcoidosis. Three
of these patients didn’t followup in our office, and we did not know the final diagnosis. One patient was
diagnosed with small cell carcinoma based on Immunohistochemical analysis of the cellblock specimen.

DISCUSSION
In 1987, Zajdela et al.[14] introduced a modified technique of performing FNA. They compared the
diagnostic yield in two groups of patients who underwent FNA for breast tumors. Both groups included
benign and malignant diagnoses. In the first group, the FNA was performed with application of negative
pressure created by a syringe and the second was when the FNA was performed without applying negative
pressure after puncturing the breast lesion. The cellular yield in suction and no suction group was 6% and
5.5% respectively, which was not statistically significant. Additionally, Santos and Leiman[17] described
the use of nonaspiration use of FNA with the same conclusion. Yue and Zheng[16] were the first to report
the use of FNA without aspiration for lung lesions. Fifteen patients underwent transthoracic lung biopsies,
11 of them had FNA without suction and 4 with suction. The diagnostic accuracy was comparable between
both techniques. The samples with no aspiration contained less blood, and the cytologic diagnosis was
easier to make. Moreover, Bhutani et al.[18] studied two metastatic LNs that were dissected at autopsy.
One of these LNs was metastatic with transitional cell bladder cancer, and the other was nonsmall cell
lung cancer. They used a 21gauge needle to perform FNA with the application of suction using 10 mL, 20
mL and 30 mL. The specimens were evaluated blindly by two Pathologists. The cellularity and the quality
of the FNA were better with less suction using the 10 mL negative pressure syringe.
In late 2000, Wallace et al.[15] were first to compare two endoscopic US FNA techniques. They used the
22gauge needle FNA with and without suction at the center and at the edge of the LNs. Totally 43 patients
were included in the final analysis, and all patients had a primary cancer most commonly lung cancer.
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4/10

3/7/2018

Comparison of cytologic accuracy of endobronchial ultrasound transbronchial needle aspiration using needle suction versus no suction

They used a 20 mL syringe for suction. Most of the LNs sampled were subcarinal (N7). 39% if the LN
were malignant. Suction significantly increased the cellularity of the samples as well as the amount of
blood. The authors did not find any significant difference concerning the diagnostic yield between the
suction versus no suction as well as between the centered versus edge directed FNA samples. Casal et al.
[19] were the first study to evaluate the EBUS needle sampling with and without suction. There were no
differences in adequacy, diagnosis, and quality between samples obtained using either way.
Our study aimed to compare the EBUSTBNA with and without suction. It showed no significant
difference in diagnosing malignant and benign diseases, which was consistent with all previous studies.
[14,15,16,17] We chose to obtain 4 passes per site based on previous data,[20,21,22] and we always had at
least two additional specimens for the cellblock the results of which were used for clinical purposes. For
the TBNANS specimen that was dry, the TBNAS was positive for malignancy, therefore, one will
conclude that the application of suction should be applied only in cases where a dry specimen is obtained
with TBNANS or FNA without suction in cases of other types and sites of tissue biopsies. Our study had
a few limitations. We did not evaluate the LN characteristics such as shape, echogenicity, margin, presence
of necrosis sign and central hilar structure. Although that we tried to take both the TBNAS and TBNANS
samples from the exact same location in the LN, some location variability still exist but thought to be
insignificant. Furthermore, all our punctures were in the center of the lymph and were not taken at the
edge. We did not compare the time of the procedure with TBNANS versus TBNAS and our patients’
malignancy was limited to lung cancers with small sample size. Finally, we did not compare the sample
adequacy for molecular testing between the two techniques.

CONCLUSION
Endobronchial ultrasoundguided transbronchial needle aspiration with suction and EBUSTBNA without
suction are both acceptable techniques for the diagnosis of mediastinal lymphadenopathy. The diagnostic
sensitivity, specificity, and specimen adequacy were not statistically significant between the two methods.
Large trials evaluating this matter are warranted and till then the choice of the technique should be left to
the personal preference of the bronchoscopist.

Footnotes
Source of Support: Nil.
Conflict of Interest: None declared.
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Table 1

Baseline characteristics of patients and lymph nodes
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Figure 1

Results by patient: Tissue adequacy and diagnostic yield comparing the two methods (transbronchial needle aspiration and
suction and endobronchial ultrasoundguided transbronchial needle aspiration and no suction)
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Figure 2

Results by site: Tissue adequacy and diagnostic yield comparing the 2 methods (transbronchial needle aspiration and
suction and endobronchial ultrasoundguided transbronchial needle aspiration and no suction)
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